agilon health, inc. (NYSE:AGL) Short Interest Up 10.5% in August

agilon health, inc. (NYSE:AGL) was the recipient of a significant growth in short interest in August. As of August 31st, there was short interest totalling 40,190,000 shares, a growth of 10.5% from the August 15th total of 36,380,000 shares. Approximately 13.3% of the company’s stock are sold short. Based on an average daily volume of 2,640,000 shares, the days-to-cover ratio is presently 15.2 days.

Insider Activity at agilon health

In other news, insider Benjamin Shaker sold 18,750 shares of the stock in a transaction that occurred on Wednesday, July 12th. The stock was sold at an average price of $16.97, for a total value of $318,187.50. Following the completion of the sale, the insider now directly owns 79,543 shares of the company’s stock, valued at $1,349,844.71. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. In related news, CAO Timothy Gertsch sold 26,250 shares of the stock in a transaction on Monday, September 11th. The stock was sold at an average price of $18.61, for a total transaction of $488,512.50. Following the completion of the sale, the chief accounting officer now directly owns 17,121 shares of the company’s stock, valued at $318,621.81. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Benjamin Shaker sold 18,750 shares of the stock in a transaction on Wednesday, July 12th. The stock was sold at an average price of $16.97, for a total value of $318,187.50. Following the sale, the insider now directly owns 79,543 shares of the company’s stock, valued at $1,349,844.71. The disclosure for this sale can be found here. Insiders sold 82,500 shares of company stock valued at $1,484,513 over the last three months. 3.60% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in the company. FMR LLC increased its position in agilon health by 17.1% during the 1st quarter. FMR LLC now owns 54,656,726 shares of the company’s stock worth $1,298,097,000 after purchasing an additional 7,985,420 shares in the last quarter. Capital World Investors increased its position in agilon health by 21.0% during the 2nd quarter. Capital World Investors now owns 51,347,600 shares of the company’s stock worth $890,367,000 after purchasing an additional 8,911,629 shares in the last quarter. Vanguard Group Inc. increased its position in agilon health by 14.7% during the 3rd quarter. Vanguard Group Inc. now owns 18,770,560 shares of the company’s stock worth $439,605,000 after purchasing an additional 2,407,116 shares in the last quarter. Wellington Management Group LLP increased its position in agilon health by 11.0% during the 1st quarter. Wellington Management Group LLP now owns 18,578,035 shares of the company’s stock worth $470,953,000 after purchasing an additional 1,834,890 shares in the last quarter. Finally, Capital Research Global Investors increased its position in agilon health by 16.6% during the 2nd quarter. Capital Research Global Investors now owns 15,203,371 shares of the company’s stock worth $263,621,000 after purchasing an additional 2,159,835 shares in the last quarter.

Wall Street Analysts Forecast Growth

Several brokerages recently weighed in on AGL. The Goldman Sachs Group decreased their price target on agilon health from $29.00 to $25.00 and set a “buy” rating for the company in a report on Tuesday, August 15th. TD Cowen decreased their price target on agilon health from $29.00 to $25.00 and set an “outperform” rating for the company in a report on Tuesday, August 15th. Truist Financial cut their price objective on agilon health from $35.00 to $27.00 in a research report on Tuesday, June 20th. Finally, Evercore ISI assumed coverage on agilon health in a research report on Tuesday, June 13th. They issued an “inline” rating and a $22.50 price objective for the company. Seven research analysts have rated the stock with a buy rating, According to data from MarketBeat.com, agilon health presently has a consensus rating of “Buy” and an average price target of $27.39.

agilon health Price Performance

Shares of AGL stock traded down $0.18 during mid-day trading on Monday, reaching $18.57. The stock had a trading volume of 2,736,784 shares, compared to its average volume of 2,844,639. agilon health has a 12-month low of $15.00 and a 12-month high of $29.44. The company has a market cap of $7.53 billion, a P/E ratio of -89.85 and a beta of 1.00. The business has a 50-day simple moving average of $18.11 and a 200 day simple moving average of $21.19. The company has a current ratio of 1.50, a quick ratio of 1.50 and a debt-to-equity ratio of 0.04.

agilon health (NYSE:AGL) last announced its quarterly earnings results on Thursday, August 3rd. The company reported ($0.04) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.03). agilon health had a negative net margin of 2.39% and a negative return on equity of 8.57%. The firm had revenue of $1.15 billion during the quarter, compared to analysts’ expectations of $1.11 billion. On average, sell-side analysts anticipate that agilon health will post -0.14 earnings per share for the current year.

About agilon health

agilon health, inc. offers healthcare services for seniors through primary care physicians in the communities of the United States. As of December 31, 2022, it served approximately 269,500 medicare advantage members and 89,000 Medicare fee-for-service beneficiaries. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.